Company led recall: Chirocaine 5mg/ml solution for injection/concentrate for solution for infusion
The Medicines and Healthcare products Regulatory Agency (MHRA) have issued a company-led recall for a specified batch of Chirocaine 5mg/ml solution for injection/concentrate for solution for infusion by Abbvie Limited.
The affected batch was intended for the Philippines and has been disturbed in the UK by mistake. Although the labelling and the patient information leaflet are in English, the text is different from the UK version and some important safety information is missing.
Further details of the alert and the affected batch are available on the MHRA website.